Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes

Clinical Chemistry

Volumn 48, Issue 12, 2002, Pages 2147-2154

  Bullock, Grant C ^a   Bruns, David E ^a   Haverstick, Doris M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MAGNESIUM;

5' UNTRANSLATED REGION; ARTICLE; AUTOMATION; DIAGNOSTIC APPROACH ROUTE; ENERGY TRANSFER; FLUORESCENCE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MELTING POINT; MOLECULAR PROBE; NONHUMAN; NUCLEIC ACID ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSOR; TEMPERATURE MEASUREMENT;

HEPATITIS C VIRUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0036892162     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.12.2147     Document Type: Article

References (24)

1. Benhamou J-P, Rodes J, Alter H. EASL international consensus conference on hepatitis C. Paris, 26-28, February 1999, consensus statement. European Association for the Study of the Liver. J Hepatol 1999;30: 956-61.
2. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C. Hepatology 1997;26: 2S-10S.
3. Germer JJ, Zein NN. Advances in the molecular diagnosis of hepatitis C and their clinical implications [Review]. Mayo Clin Proc 2001;76: 911-20.
4. Zein NN. Clinical significance of hepatitis C virus genotypes [Review]. Clin Microbiol Rev 2000;13: 223-35.
5. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244: 359-62.
6. Chen PJ, Lin MH, Tai KF, Liu PC, Lin CJ, Chen DS. The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA. Virology 1992;188: 102-13.
7. Delisse AM, Descurieux M, Rutgers T, D'Hondt E, De Wilde M, Arima T, et al. Sequence analysis of the putative structural genes of hepatitis C virus from Japanese and European origin. J Hepatol 1991;13: S20-3.
8. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990;170: 1021-5.
9. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Mori S, Hijikata M, et al. Distribution of plural HCV types in Japan. Biochem Biophys Res Commun 1991;181: 279-85.
10. Li JS, Tong SP, Vitvitski L, Lepot D, Trepo C. Evidence of two major genotypes of hepatitis C virus in France and close relatedness of the predominant one with the prototype virus. J Hepatol 1991;13: S33-7.
11. Li JS, Tong SP, Vitvitski L, Lepot D, Trepo C. Two French genotypes of hepatitis C virus: Homology of the predominant genotype with the prototype American strain. Gene 1991;105: 167-72.
12. Maertens G, Stuyer L. Genotypes and Genetic Variation of Hepatitis C Virus. In: Harrison T, Zuckermanm A, eds. The molecular medicine of viral hepatitis. New York: John Wiley, 1997: 183-234.
13. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991;175: 220-8.
14. Han JH Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, et al. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci U S A 1991;88: 1711-5.
15. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC Trepo C, et al. Interferon α-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998;339: 1493-9.
16. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998;339: 1485-92.
17. Krekulova L, Rehak V, Wakil AE, Harris E, Riley LW. Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): A rapid method to distinguish HCV subtype 1b from other genotypes. J Clin Microbiol 2001;39: 1774-80.
18. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998;352: 1426-32.
19. Ross RS, Viazov SO, Holtzer CD, Beyou A, Monnet A, Mazure C, et al. Genotyping of hepatitis C virus isolates using CLIP sequencing. J Clin Microbiol 2000;38: 3581-4.
20. Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, et al. Decrease in serum hepatitis C viral RNA during α-interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115: 700-4.
21. Allawi HT, SantaLucia J Jr. Thermodynamics and NMR of internal G.T mismatches in DNA. Biochemistry 1997;36: 10581-94.
22. Gray DM. Derivation of nearest-neighbor properties from data on nucleic acid oligomers. I. Simple sets of independent sequences and the influence of absent nearest neighbors. Biopolymers 1997;42: 783-93.
23. Mitchell PS, Sloan LM, Majewski DW, Rys PN, Heimgartner PJ, Rosenblatt JE, et al. Comparison of line probe assay and DNA sequencing of 5′ untranslated region for genotyping hepatitis C virus: Description of novel line probe patterns. Diagn Microbiol Infect Dis 2002;42: 175-9.
24. Schroter M, Zollner B, Schafer P, Landt O, Lass U, Laufs R, et al. Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes. J Clin Microbiol 2002;40: 2046-50.